| Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease RM Gadaleta, KJ Van Erpecum, B Oldenburg, ECL Willemsen, W Renooij, ... Gut 60 (4), 463-472, 2011 | 740 | 2011 |
| Androgen signaling negatively controls group 2 innate lymphoid cells S Laffont, E Blanquart, M Savignac, C Cénac, G Laverny, D Metzger, ... Journal of Experimental Medicine 214 (6), 1581-1592, 2017 | 255 | 2017 |
| Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation G Penna, B Fibbi, S Amuchastegui, C Cossetti, F Aquilano, G Laverny, ... The Journal of Immunology 182 (7), 4056-4064, 2009 | 195 | 2009 |
| The vitamin D receptor agonist elocalcitol inhibits IL‐8‐dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho … G Penna, B Fibbi, S Amuchastegui, E Corsiero, G Laverny, E Silvestrini, ... The Prostate 69 (5), 480-493, 2009 | 145 | 2009 |
| Mitochondria: an organelle of bacterial origin controlling inflammation A Meyer, G Laverny, L Bernardi, AL Charles, G Alsaleh, J Pottecher, ... Frontiers in immunology 9, 536, 2018 | 129 | 2018 |
| Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease G Laverny, G Penna, S Vetrano, C Correale, M Nebuloni, S Danese, ... Immunology letters 131 (1), 49-58, 2010 | 108 | 2010 |
| IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis A Meyer, G Laverny, Y Allenbach, E Grelet, V Ueberschlag, ... Acta neuropathologica 134, 655-666, 2017 | 99 | 2017 |
| The transcriptional coregulator PGC-1β controls mitochondrial function and anti-oxidant defence in skeletal muscles T Gali Ramamoorthy, G Laverny, AI Schlagowski, J Zoll, N Messaddeq, ... Nature communications 6 (1), 10210, 2015 | 79 | 2015 |
| Immunomodulatory properties of multi-walled carbon nanotubes in peripheral blood mononuclear cells from healthy subjects and allergic patients G Laverny, A Casset, A Purohit, E Schaeffer, C Spiegelhalter, F de Blay, ... Toxicology Letters 217 (2), 91-101, 2013 | 56 | 2013 |
| Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells G Penna, S Amuchastegui, G Laverny, L Adorini Journal of Bone and Mineral Research 22 (S2), V69-V73, 2007 | 56 | 2007 |
| Vitamin D and calcium intakes in general pediatric populations: A French expert consensus paper J Bacchetta, T Edouard, G Laverny, J Bernardor, A Bertholet-Thomas, ... Archives de Pédiatrie 29 (4), 312-325, 2022 | 54 | 2022 |
| A vitamin D receptor selectively activated by gemini analogs reveals ligand dependent and independent effects T Huet, G Laverny, F Ciesielski, F Molnár, TG Ramamoorthy, ... Cell reports 10 (4), 516-526, 2015 | 52 | 2015 |
| Synthesis and Anti-inflammatory Properties of 1α,25-Dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a Hypocalcemic, Stable Metabolite of 1α,25-Dihydroxy-16-ene-20 … G Laverny, G Penna, M Uskokovic, S Marczak, H Maehr, P Jankowski, ... Journal of medicinal chemistry 52 (8), 2204-2213, 2009 | 47 | 2009 |
| Diabetes worsens skeletal muscle mitochondrial function, oxidative stress, and apoptosis after lower-limb ischemia-reperfusion: implication of the RISK and SAFE pathways? J Pottecher, C Adamopoulos, A Lejay, J Bouitbir, AL Charles, A Meyer, ... Frontiers in Physiology 9, 579, 2018 | 33 | 2018 |
| Vitamin D receptor agonists as anti-inflammatory agents L Adorini, S Amuchastegui, E Corsiero, G Laverny, T Le Meur, G Penna Expert Review of Clinical Immunology 3 (4), 477-489, 2007 | 30 | 2007 |
| A new murine model of sustainable and durable chronic critical limb ischemia fairly mimicking human pathology A Lejay, P Choquet, F Thaveau, F Singh, A Schlagowski, AL Charles, ... European Journal of Vascular and Endovascular Surgery 49 (2), 205-212, 2015 | 28 | 2015 |
| Phospholipid–Detergent Conjugates as Novel Tools for siRNA Delivery P Pierrat, G Laverny, G Creusat, P Wehrung, JM Strub, A VanDorsselaer, ... Chemistry–A European Journal 19 (7), 2344-2355, 2013 | 26 | 2013 |
| A cationic phospholipid–detergent conjugate as a new efficient carrier for siRNA delivery P Pierrat, G Creusat, G Laverny, F Pons, G Zuber, L Lebeau Chemistry–A European Journal 13 (18), 3835-3839, 2012 | 24 | 2012 |
| PGC-1β modulates statin-associated myotoxicity in mice F Singh, J Zoll, U Duthaler, AL Charles, MV Panajatovic, G Laverny, ... Archives of toxicology 93, 487-504, 2019 | 23 | 2019 |
| Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression MA Abu el Maaty, J Terzic, C Keime, D Rovito, R Lutzing, D Yanushko, ... Science Advances 8 (29), eabo2295, 2022 | 19 | 2022 |
